Jakavi 5 mg Tablets – Ruxolitinib (Novartis)

Brand: Jakavi
Generic Name: Ruxolitinib
Strength: 5 mg
Manufacturer: Novartis
Use: Myelofibrosis, Polycythemia Vera, GVHD

• Overview: Jakavi is the original Ruxolitinib brand by Novartis for hematological disorders

• Benefits: Controls spleen size, fatigue, abnormal blood cell proliferation

• Dosage: As per hematologist; 5 mg usually for mild cases

• Jakavi 5 mg, Ruxolitinib, Myelofibrosis tablet, PV medication